Heart News and Research

RSS

ARCA biopharma regains compliance for continued listing on NASDAQ

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that it received notification from the NASDAQ Stock Market that the Company has demonstrated compliance with the minimum stockholders' equity requirement for the NASDAQ Global Market

13 May 2010

Stereotaxis to be featured prominently in 31st HRS

Stereotaxis' safety and efficacy in the treatment of patients with complex arrhythmias such as atrial fibrillation, ventricular tachycardia, and congenital heart defects will be featured prominently in the scientific program of the 31st Annual Heart Rhythm Scientific Sessions in Denver, Colorado. Eight podium presentations and eight posters will underscore the broad clinical leadership that Stereotaxis has achieved in the treatment of patients with complex cardiac arrhythmias.

13 May 2010

SAGE launches further two Therapeutic Advances journals

SAGE has extended its suite of Therapeutic Advances journals with the launch of a further two titles: Therapeutic Advances in Chronic Disease and Therapeutic Advances in Endocrinology and Metabolism.

13 May 2010

Cancer Research UK to unveil its eighth garden at Chelsea Flower Show 2010

Cancer Research UK will unveil its eighth garden at Chelsea Flower Show 2010 (25 - 29 May 2010), designed for the second year running by four-time gold medal winner, Robert Myers.

13 May 2010

Researchers to discuss various implications for personalized medicine during one-day symposium

On May 27, researchers with the National Human Genome Research Institute and the National Cancer Institute, along with Group Health Cooperative in Seattle and Henry Ford Health System, will debate and discuss that question during the one-day symposium "Multiplex Initiative: Implications for Personalized Medicine."

13 May 2010

Children and young adults account for as many as 10% of all stroke cases

The news that Vice President Joe Biden's 41-year-old son has suffered a stroke is highlighting the problem of strokes in young people.

13 May 2010

Individual's lifestyle choices can affect cholesterol, triglycerides levels: Mayo Clinic Health Letter

Diet and lifestyle choices aren't only evident on the bathroom scale. The effect of these choices is also reflected with relative accuracy in cholesterol numbers.

13 May 2010

Study: Treating serious gum disease in diabetics can help lower blood sugar levels

Researchers have found that reducing inflammation of the gums in people with diabetes can help lower the risk of serious complications associated with the condition, such as eye problems and heart disease.

13 May 2010

New Melody Transcatheter Pulmonary valve helps congenital heart defect patients avoid multiple surgeries

Congenital heart defects are the most common type of major birth defect in the U.S., affecting about 25,000 babies each year. Now, a new valve being used at the University of Michigan's C.S. Mott Children's Hospital Congenital Heart Center can help patients delay or avoid multiple surgeries.

13 May 2010

Research sheds light on prenatal heart formation, chromosome 22q.11 deletion syndrome

Researchers studying the common genetic disorder chromosome 22q.11 deletion syndrome have identified key proteins that act together to regulate early embryonic development. One protein is essential to life; in animal studies, embryos without the protein do not survive past the first few days of gestation.

13 May 2010

St. Jude Medical to display new products, clinical solutions at Heart Rhythm 2010

St. Jude Medical, Inc., a global medical device company, today announced it will display a number of new products and clinical solutions from the company's Cardiac Rhythm Management and Atrial Fibrillation Divisions at Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions.

13 May 2010

FDA should apply equal rigor in assessing food claims and drug approvals, says new report

The U.S. Food and Drug Administration should apply the same rigor to evaluating the science behind claims of foods' and nutritional supplements' health benefits as it devotes to assessing medication and medical technology approvals, says a new report from the Institute of Medicine.

13 May 2010

Resverlogix' Phase 2 ASSERT trial dosing complete ahead of schedule

Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. "The completion of dosing for our Phase 2 ASSERT trial, five months ahead of schedule and without any alterations to the dose levels of the three drug receiving cohorts, is another major step forward in the development of this important cardiovascular drug.

13 May 2010

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Boston Scientific Corporation today announced it has received CE Mark approval for its TAXUS Element Paclitaxel-Eluting Coronary Stent System, the Company's third-generation drug-eluting stent technology. This approval includes a specific indication for the treatment of diabetic patients.

13 May 2010

Mayo Clinic Women's HealthSource offers information about abdominal aortic aneurysms

Abdominal aortic aneurysms have been considered mainly a man's problem. Men, more often than women, develop a weakened and bulging area in the aorta, the body's largest artery, which poses a risk of rupture. But according to the May issue of Mayo Clinic Women's HealthSource, women aren't risk free.

13 May 2010

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) approval and first U.S. implants of its Unify™ cardiac resynchronization therapy defibrillator (CRT-D) and Fortify™ implantable cardioverter defibrillator (ICD). The new devices feature advanced battery technology and circuitry that allow for the smallest device footprint in the industry and rapid charge times, without any compromise in device longevity or power.

13 May 2010

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Angiotech Pharmaceuticals, Inc. today announced that its corporate partner, Boston Scientific Corporation, has received CE Mark approval for its TAXUS(R) Element(TM) Paclitaxel-Eluting Coronary Stent System, Boston Scientific's third-generation drug-eluting stent (DES) technology.

13 May 2010

FDA approves Evia pacemaker for distribution in the U.S.

BIOTRONIK today announced that the U.S. Food and Drug Administration has cleared the Evia pacemaker for distribution in the U.S., giving physicians and patients access to a unique Bradycardia system designed and manufactured with BIOTRONIK's unparalleled legacy of quality.

13 May 2010

Nurses give evidence of the horrifying day in Dr. Jayant Patel’s surgery

The trial of Dr. Jayant Patel continues. In recent evidence at the court one of the operating theatre nurses revealed under oath to the Brisbane Supreme Court how staff had tried to deter former Bundaberg-based surgeon Jayant Patel from transferring an unstable patient from the theatre to ICU, where he died. There was earlier evidence that the man was bleeding uncontrollably and also allegations that Patel urged junior doctors not to tell anyone what happened.

12 May 2010

More for mental health and first nurse led clinic

Tuesday’s budget saw the Australian government allocate $7.4 billion for health. Many critics have brought to notice that only $200 million has gone towards mental health. The Rudd government has denied such accusations.

12 May 2010

Heart News and Research

ARCA biopharma regains compliance for continued listing on NASDAQ

Stereotaxis to be featured prominently in 31st HRS

SAGE launches further two Therapeutic Advances journals

Cancer Research UK to unveil its eighth garden at Chelsea Flower Show 2010

Researchers to discuss various implications for personalized medicine during one-day symposium

Children and young adults account for as many as 10% of all stroke cases

Individual's lifestyle choices can affect cholesterol, triglycerides levels: Mayo Clinic Health Letter

Study: Treating serious gum disease in diabetics can help lower blood sugar levels

New Melody Transcatheter Pulmonary valve helps congenital heart defect patients avoid multiple surgeries

Research sheds light on prenatal heart formation, chromosome 22q.11 deletion syndrome

St. Jude Medical to display new products, clinical solutions at Heart Rhythm 2010

FDA should apply equal rigor in assessing food claims and drug approvals, says new report

Resverlogix' Phase 2 ASSERT trial dosing complete ahead of schedule

BSX receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

Mayo Clinic Women's HealthSource offers information about abdominal aortic aneurysms

FDA approves St. Jude Medical's Unify CRT-D and Fortify ICD devices

Boston Scientific receives CE Mark approval for TAXUS Element Paclitaxel-Eluting Coronary Stent System

FDA approves Evia pacemaker for distribution in the U.S.

Nurses give evidence of the horrifying day in Dr. Jayant Patel’s surgery

More for mental health and first nurse led clinic

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News